evelyn-bowen documents

Results of COMFORT-I, a Randomized Double-Blind, Phase III Trial of JAK1/JAK2 Inhibitor Ruxolitinib (INCB18424) vs Placebo for Patients with Myelofibrosis
Documents Results of COMFORT-I, a Randomized Double-Blind, Phase III Trial of JAK1/JAK2 Inhibitor Ruxolitinib (INCB18424) vs Placebo for Patients with Myelofibrosis
WISeWorld conference 20001128 Information Risk Management kpmg PKI: Panacea or Pandora? Arjen van Zanten Partner, KPMG IRM, The Netherlands International
Documents WISeWorld conference 20001128 Information Risk Management kpmg PKI: Panacea or Pandora? Arjen van Zanten Partner, KPMG IRM, The Netherlands International
LinkFinderPlus at the University of Edinburgh – the story so far…… Liz Stevenson Edinburgh University Library
Documents LinkFinderPlus at the University of Edinburgh – the story so far…… Liz Stevenson Edinburgh University Library